Ranawara (Cassia Auriculata) Sourcing Spec

Buyer’s snapshot

In 2024, the CDC put US prediabetes at 115.2 million adults, more than two in five, and the global detox-tea category is on track for roughly USD 3.5 billion in 2026 (Straits Research, 2025), pulling demand toward less commodified Ayurvedic botanicals than turmeric or ginger.

Ranawara (Cassia auriculata) carries a documented alpha-glucosidase inhibitory mechanism comparable to acarbose (AIMS Agriculture and Food, 2024) and a multi-part traditional-use record in Ayurveda, but the human clinical base is thin. The honest label position is structure-support language, not a disease claim.

Silk Foods Ceylon (SFC) processes ranawara at its Matale spice line into whole, tea-cut, and powder formats under BRCGS and FSSC 22000 V6, with a 50 kg first-order MOQ per SKU and per-batch COA.

This is the sourcing and claims-framing spec Silk Route Ventures (SRV) built for wellness and specialty-tea brands adding a blood-sugar-support or detox SKU. It is not a substitute for a review by the brand’s own regulatory counsel.

Most US and EU tea and supplement brands sourcing a blood-sugar-support or detox botanical from Sri Lanka default to the same three names: gymnema, moringa, gotukola. Ranawara (Cassia auriculata) rarely makes the shortlist, despite nearly three thousand years of documented Ayurvedic use across five separate plant parts and a 2024 peer-reviewed review crediting its flavonoid fraction with alpha-glucosidase inhibition on par with acarbose. The gap is not evidence. It is sourcing infrastructure. Most Sri Lankan exporters sell ranawara as a whole dried flower for the tourist tea-bag trade, not as a species-verified, batch-tested raw material a nutraceutical formulator can put a claim behind. This piece is the sourcing spec for the brands ready to close that gap.

What ranawara is, and why wellness brands are asking for it now

Ranawara is the Sinhala name for Cassia auriculata, reclassified in some taxonomies as Senna auriculata, a yellow-flowered shrub in the Fabaceae family known in English as tanner’s cassia or avaram. Sri Lankan and South Indian Ayurveda has used its flowers, leaves, bark, root, and seed since at least the 15th-century Kaiyadeva Nighantu, each part assigned a distinct application: flowers for diabetes, tender fruits for thirst and eye conditions, roots for asthma and hemorrhage, seeds as an antidote (Frontiers in Pharmacology, 2021).

The renewed commercial interest is demand-side, not supply-side. In 2024, the US Centers for Disease Control and Prevention counted 115.2 million American adults with prediabetes, more than two in five of the adult population, and the global detox-tea market is projected to reach approximately USD 3.5 billion in 2026 (Straits Research, 2025). Brands chasing that growth have largely exhausted the obvious Ceylon botanicals. Ranawara is one of the few with a real pharmacological literature behind it that most Western formulators have not yet specified. Sri Lankan households, meanwhile, have brewed the dried flowers as an everyday, caffeine-free tea for generations; the “discovery” is entirely a Western sourcing-desk phenomenon.

Buyers running this same spec-versus-claim discipline across the category can cross-check against sourcing functional herbs and Ayurvedic botanicals from Sri Lanka, gotukola powder for cognitive nutraceutical SKUs, and guduchi powder for immunity-claim nutraceutical SKUs.

What does the pharmacological evidence say about ranawara and blood sugar?

A 2021 review in Frontiers in Pharmacology found Cassia auriculata inhibits alpha-amylase and alpha-glucosidase, the enzymes that break dietary starch into absorbable glucose, while also supporting insulin secretion in animal models. A 2024 review in AIMS Agriculture and Food described the same alpha-glucosidase inhibition as comparable to acarbose, a prescription diabetes drug, attributed to a flavonoid and anthraquinone fraction that includes quercetin, kaempferol, and rutin.

The dosing data comes almost entirely from animal studies: leaf extracts reduced fasting blood glucose 13.9 to 17.4 percent in diabetic rats within five hours, and seed extract at 300 to 400 mg per kg produced reductions the reviewers called comparable to metformin (Frontiers in Pharmacology, 2021). Human evidence is thinner. One small trial using a polyherbal formulation reduced fasting and postprandial glucose against a glimepiride comparator over two months; a second reported a significant reduction with aqueous flower extract over 30 days. Neither trial size meets the bar most Western regulators expect for a disease claim.

One finding buyers should not skip: the same 2021 review documented herb-drug interactions, including a 60 percent reduction in metformin absorption with a supercritical Cassia auriculata extract, and elevated blood levels of theophylline and carbamazepine with concurrent use. A brand formulating for a population that may already be on diabetes medication needs that interaction data in its own labeling and disclaimer review, alongside the traditional-use story.

Spec snapshot: Ranawara (Cassia auriculata), raw material

Botanical name: Cassia auriculata (syn. Senna auriculata)

Plant parts supplied: flower, leaf, whole pod (root and bark on request)

Documented actives: flavonoids (quercetin, kaempferol, rutin), anthraquinones, phenolic acids

Formats: whole dried flower/leaf, tea cut (1 to 3 mm), fine powder

SRV MOQ: 50 kg first order per SKU; sample dispatch by international courier, 3 to 5 business days

Ranawara powder vs. tea cut: choosing the format for a blood-sugar-support or detox-tea SKU

The format decision comes down to the SKU, not the botanical. A pyramid or filter-paper tea bag needs a coarser tea cut that infuses cleanly without clouding the cup; a capsule or drink-mix SKU needs a fine powder that disperses fully and delivers a consistent dose. Buyers who order the wrong cut usually find out at the co-packing stage, when the tea-bag line rejects an over-fine powder or the capsule line rejects an under-milled cut.

Attribute	Tea cut (loose or bagged)	Fine powder
Typical particle size	1 to 3 mm cut	80 to 100 mesh fine powder
Best-fit SKU	Loose-leaf or tea-bag infusion	Capsule, drink mix, or blended powder
Brew or dose behavior	3 to 5 minute steep, lighter cup	Full dose per serving, no steeping
Typical shelf life, sealed	18 to 24 months	12 to 18 months (faster oxidation)
Packaging formats available	Pyramid, round paper, string-and-tag, filter bags	Kraft pouch, capsule fill, bulk sack
SRV first-order MOQ	50 kg per SKU	50 kg per SKU (180 bottles if encapsulated)

Source: SFC facility processing data.

For a detox-tea private-label programme, the tea-cut format runs on SRV’s Functional Tea Bags line, detailed in Ceylon tea bag formats: pyramid, round paper, string and tag, available in pyramid, round paper, string-and-tag, or filter-paper formats under FSSC 22000 V6. For a capsule or powder-blend SKU, the same raw material runs through the spice line at 100 to 200 kg per hour into a fine powder, ready for encapsulation or private-label pouching.

Where ranawara grows, and what that sourcing geography means for a buyer

Ranawara grows wild and semi-cultivated across Sri Lanka’s dry and intermediate zones, most densely in the scrub country of Moneragala, Hambantota, and Anuradhapura districts, where annual rainfall runs 900 to 1,500 mm against Matale’s wetter mid-elevation belt. The plant tolerates the poor, well-drained soils of the dry zone better than most cultivated herbs, part of why it has stayed a wild-harvested, smallholder-supplied crop rather than a plantation monoculture.

In Q2 2026, the SRV procurement desk started fielding a new pattern: specialty-tea and wellness brands asking for Ceylon botanicals beyond the four or five names in every competitor’s catalogue, specifically for detox and metabolic-support tea-bag lines. Ranawara, along with polpala, kept coming up: herbs Sri Lankan households have always used but that had no export-grade spec attached. Raw ranawara from the dry zone now travels to the SFC facility in Matale, 1 km from Nalanda Gedige, for cutting, grinding, and packing under the same BRCGS and FSSC 22000 V6 scope covering the rest of the Ceylon Herbs category, with species verification and a heavy-metals and microbial panel on every batch.

How does ranawara compare to gymnema (gurmar) for a blood-sugar-support claim?

Ranawara and gymnema get requested for the same brief, a blood-sugar or metabolic-support SKU, but they don’t sit on the spec sheet the same way. Gymnema’s actives (gymnemic acids) assay to a defined percentage, giving a clean standardized-extract claim path. Ranawara’s flavonoid and anthraquinone fraction is not yet standardized to a single marker, so most ranawara SKUs ship as a whole-herb spec rather than a percentage-assayed extract.

Attribute	Ranawara (Cassia auriculata)	Gymnema sylvestre (gurmar)
Primary active class	Flavonoids (quercetin, kaempferol, rutin), anthraquinones	Gymnemic acids (triterpenoid saponins)
Documented mechanism	Enzyme inhibition, insulin-secretion support	Blunts sweet taste, slows glucose absorption
Assay basis	Whole-herb spec, no single marker yet	Gymnemic-acid percent (25 or 75 percent extract)
Human clinical evidence	Limited: small polyherbal trials	Stronger: 2024 RCT (Nutrients), 2021 meta-analysis
Typical formats supplied	Whole, tea cut, powder	Leaf powder, standardized extract, capsule
SRV first-order MOQ	50 kg per SKU	50 kg per SKU

Source: SFC facility data; Frontiers in Pharmacology, 2021; AIMS Agriculture and Food, 2024.

The honest read for a buyer: gymnema currently carries the stronger, more standardized human evidence base, while ranawara offers a longer and more varied traditional-use record plus a distinct mechanism, enzyme inhibition and beta-cell support rather than taste-blunting and absorption delay. Brands building a broader metabolic-support line often specify both, positioned on different mechanisms rather than as substitutes.

The full spec for the comparison botanical is in Gymnema Sylvestre (Gurmar): A Sourcing Spec for Blood-Sugar SKUs.

Specifying ranawara in an RFQ: what to ask for

Buyer’s checklist: specifying ranawara (Cassia auriculata)

Botanical species confirmed in writing (Cassia auriculata, syn. Senna auriculata), plant part(s) specified

Format locked to the SKU: whole, tea cut (state mm range), or fine powder (state target mesh)

Per-batch COA covering moisture, microbial count, heavy metals, and a pesticide residue panel for the destination market

Supplier’s cert stack confirmed in writing: BRCGS, FSSC 22000 V6, and USDA or EU Organic if claimed

Drug-interaction and contraindication review folded into the brand’s own label and disclaimer copy

Sample dispatched against the exact format spec before the first purchase order

For the general RFQ mechanics, How to Write a Spice RFQ: Specs, Certifications, and MOQ Questions covers the same document checklist in more depth.

Certification snapshot: Silk Foods Ceylon, Matale

BRCGS (covers herb, spice, and tea processing lines)

FSSC 22000 V6 (covers the full herb and capsule processing scope)

USDA Organic and EU Organic (per SKU)

Registered with Sri Lanka’s Department of Ayurveda (herbal capsule line)

What claims can a US or EU brand actually make about Cassia auriculata?

In the US, a structure-function claim, for example “supports healthy blood sugar already within a normal range,” is permitted under 21 CFR 101.93 without FDA pre-approval, provided the label carries the mandatory disclaimer that the statement has not been evaluated by the FDA and the product is not intended to diagnose, treat, cure, or prevent disease (US FDA, 21 CFR 101.93). A claim that crosses into “treats,” “cures,” or “prevents diabetes” reclassifies the product as an unapproved drug.

In the EU, Cassia auriculata does not appear on the European Commission’s Novel Food Status Catalogue, which puts the burden on the brand to demonstrate significant EU consumption before 15 May 1997, or to secure a novel food authorization. The honest answer for an EU-bound brand is to confirm status with its national competent authority before launch, not to assume a traditional Sri Lankan tea automatically clears EU market access (European Commission, Novel Food Status Catalogue, retrieved 2026-09-23).

Given the thin human clinical base and the documented drug interactions, SRV’s own framing for ranawara is traditional-use and structure-support language only, never a disease claim. Buyers building a claim on the raw material still carry that review with their own regulatory counsel; the spec does not substitute for it.

Frequently asked questions

Is ranawara the same plant as Cassia auriculata?

Yes. Ranawara is the Sinhala name for Cassia auriculata, reclassified in some taxonomies as Senna auriculata, a yellow-flowered Fabaceae shrub used in Sri Lankan and South Indian Ayurveda for at least five centuries (Frontiers in Pharmacology, 2021), also traded as tanner’s cassia or avaram.

Can a US brand claim ranawara treats or lowers blood sugar?

Not without becoming a drug claim. Under 21 CFR 101.93, US brands can use a structure-function statement with the mandatory FDA disclaimer, but “treats,” “cures,” or “prevents diabetes” language reclassifies the product as a drug (US FDA, 21 CFR 101.93).

Does Cassia auriculata interact with diabetes medication like metformin?

Yes. A 2021 review in Frontiers in Pharmacology reported a 60 percent reduction in metformin absorption with a supercritical extract, plus elevated theophylline and carbamazepine levels with concurrent use, data brands should carry into their own label warnings.

What is the MOQ and lead time for ranawara powder or tea cut from SFC?

First-order MOQ is 50 kg per SKU. Sample dispatch runs 3 to 5 business days by international courier; production lead time from PO to dispatch is 2 to 3 weeks.

Can SRV private-label a ranawara tea-bag SKU?

Yes. SRV’s Functional Tea Bags line runs pyramid, round paper, string-and-tag, and filter-paper formats under FSSC 22000 V6, alongside bulk supply of the same raw material for a brand’s existing co-packer.

How Silk Route Ventures can help

Silk Route Ventures (SRV) supplies ranawara (Cassia auriculata) as whole, tea-cut, and powder raw material, alongside private-label tea-bag and capsule production, from the BRCGS and FSSC 22000 V6 audited Silk Foods Ceylon (SFC) facility in Matale. First-order MOQ is 50 kg per SKU, with per-batch COA and samples shipped by international courier in 3 to 5 business days. For brands assembling a broader metabolic-support or detox-tea range, the SRV R&D and NPD team also develops multi-botanical blends alongside ranawara, gymnema, and the rest of the Ceylon Herbs category. Contact us to send an inquiry or request a sample.

Sources

US Food and Drug Administration, “21 CFR 101.93, Certain types of statements for dietary supplements.” Retrieved 2026-09-23. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-F/section-101.93
European Commission, “Novel Food Status Catalogue.” Retrieved 2026-09-23. https://food.ec.europa.eu/food-safety/novel-food/novel-food-status-catalogue_en
Centers for Disease Control and Prevention, “National Diabetes Statistics Report (2024).” Retrieved 2026-09-23. https://www.cdc.gov/diabetes/php/data-research/index.html
Frontiers in Pharmacology, “Ethnopharmacological, Phytochemical, Pharmacological, and Toxicological Review on Senna auriculata (L.) Roxb.: A Special Insight to Antidiabetic Property (2021).” Retrieved 2026-09-23. https://pmc.ncbi.nlm.nih.gov/articles/PMC8423098/
AIMS Agriculture and Food, “Cassia auriculata L., a mini review of phytochemical and pharmacological aspects (2024).” Retrieved 2026-09-23. https://www.aimspress.com/article/doi/10.3934/agrfood.2024022
Straits Research, “Detox Tea Market report (2025).” Retrieved 2026-09-23. https://straitsresearch.com/report/detox-tea-market

Ranawara (Cassia Auriculata) Sourcing Spec for Diabetes-Support Teas